Graphene specialist agrees European deal for biosensor chip
Graphene specialist Versarien has agreed a deal to distribute a new biosensor chip across Europe which is hoped to be the first in a range of sensor products developed on a new platform technology.
The technology – graphene barristor devices – has been developed by A Barristor Company in South Korea. The company has the ambition of leading the shift from transistors to graphene barristors in electronic devices.
The chip will use chemical vapour deposition (CVD) grown graphene, that is produced under a Versarien licence.
It is expected that the CVD graphene used in the products will be supplied by Korean company MCK Tech, which is an existing licencing partner of Versarien, and it will also undertake some of the device fabrication.
Versarien chief executive Dr Stephen Hodge said: “It is exciting to see this sensor platform come to fruition and I anticipate it will drive significant advancements in medical diagnostics.
“This agreement will allow Versarien to further benefit from the IP licenced to MCK Tech and we look forward to continuing to work with ABC both regarding the newly launched biosensors and as they expand their sensor capabilities.”
The range of sensor products to be distributed by Versarien may be expanded at a later date based on ABC’s product developments, such as in infrared detection, gas/chemical detection, temperature detection or multiple sensor on a chip technology.
The deal is good news for the Forest of Dean company, which has endured a difficult couple of years. The AIM-listed company has been forced to raise £4m in eight placings since March 2023, but its closing share price on Friday of 0.035p gives it a market value of just £1.45m.
